Jean-Charles Soria

Jean-Charles Soria holds the position of Senior Vice President of Research and Development at Amgen, where he also serves as the senior vice president of Oncology within Global Development. He has been elected to the American Association for Cancer Research (AACR) Board of Directors for the 2024-2027 term. Soria actively contributes to the AACR’s peer-reviewed journals, serving as a scientific editor for Cancer Discovery and deputy editor for Clinical Cancer Research. He is a member of the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research Committee and has previously served on the AACR Exploratory IND/Phase 0 Clinical Trials Task Force and the AACR COVID-19 and Cancer Task Force. Additionally, he is the vice chair of the Annual Meeting Program Committee for the AACR. Soria holds both an MD and a PhD and has a longstanding engagement with the AACR. His research focuses on the potential of targeting FGFR2b protein overexpression in gastric cancer, and he has been involved in the development of targeted therapies for cancer.